Connect with us

Hi, what are you looking for?


Commission buys COVID vaccine from Spain’s HIPRA

The European Commission has closed a deal for up to 250 million doses of the coronavirus vaccine developed by Spanish pharmaceutical company HIPRA, it announced Tuesday.

The vaccine is still being assessed. The European Medicines Agency in March started a rolling review of the shot, which is designed to protect against both the Alpha and Beta variants of the coronavirus, and would be deployed as a booster.

The Commission said that 14 countries are participating in the joint procurement. If the vaccine is approved, they will be able to put in orders on the terms negotiated by the Commission. Those terms were not disclosed.

Unlike most widely used mRNA vaccines, HIPRA’s protein-based jab can be stored at relatively warm temperatures of between 2 and 8 degrees Celsius, making it easier to handle. HIPRA makes veterinary medicines, but pivoted to the development of a protein-based vaccine against COVID-19 after the start of the pandemic.

While the vaccine awaits a final assessment, Spain’s IrsiCaixa research institute said in July that a number of studies indicate the vaccine is able to induce an antibody response protecting against all of the commonly circulating coronavirus variants.

“With COVID-19 infections on the rise in Europe, we need to ensure maximum preparedness as we head into the autumn and winter months,” said Health Commissioner Stella Kyriakides. “The HIPRA vaccine adds yet another option to complement our broad vaccine portfolio.”

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like


Ivor Ichikowitz is an industrialist and philanthropist. He is the chair of the Ichikowitz Family Foundation, which paid for the installation of the Mandela...


The European Medicines Agency has given the green light for countries to carry out a dose-sparing strategy as limited supplies of the monkeypox vaccine...


Press play to listen to this article European farmers are reckoning with the prospect of a future where parched pastures and shriveled fruits are...


The World Health Organization’s immunization advisory group Thursday recommended a second COVID-19 vaccine booster for older people, health care workers, and people at high...


Patients recovering from coronavirus infection suffer from increased rates of neurological and psychological problems, according to a wide-ranging observational study published Thursday. Researchers from...


Luis Garicano has been vice president and economics spokesman of Renew Europe and head of Spain’s Ciudadanos delegation in the European Parliament over the...


Throughout all of July, Europe’s six largest countries offered Ukraine no new bilateral military commitments, according to new data — the first month that...


The World Health Organization said Wednesday that the monkeypox vaccine is not a “silver bullet,” with the health body beginning to receive reports of...